Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3997121 | Revista Colombiana de Cancerología | 2015 | 8 Pages |
Abstract
Although overall survival rate is the gold standard in cancer therapy, it is not the most often used outcome. Intermediate outcomes, such as disease-free survival or biomarkers are often good predictors, and require smaller samples and less follow-up time. Nevertheless, their predictive capacity for overall survival rate (or, in some cases, quality of life) should also be assessed. The use of the overall survival rate as the routine primary outcome is only justified in the most aggressive forms of cancer.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Diego Rosselli, Carlos Eduardo DÃaz, Laura Gutiérrez,